Evaluating the Strategies on Ethical Grounds for Phase 0 Oncology Clinical Trials

, , , &
Journal of Clinical Research and Bioethics 2 (2) (2011)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.4172/2155-9627.1000110

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,438

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Are Phase 1 Trials Therapeutic? Risk, Ethics, and Division of Labor.James A. Anderson & Jonathan Kimmelman - 2012 - Bioethics 28 (3):138-146.
Ethical Difficulties with Randomized Clinical Trials Involving Cancer Patients: Examples from the Field of Gynecologic Oncology.Maurie Markman - 1992 - Journal of Clinical Ethics 3 (3):193-195.
Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is it Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - American Journal of Bioethics Neuroscience 3 (2):20-22.
A call to restructure the drug development process: Government over-regulation and non-innovative late stage (phase III) clinical trials are major obstacles to advances in health care.Thomas C. Jones - 2005 - Science and Engineering Ethics 11 (4):575-587.
The Ethics of Phase I Pediatric Oncology Trials.Terrence F. Ackerman - 1995 - IRB: Ethics & Human Research 17 (1):1.
Ethical Considerations for Volunteer Recruitment of Visual Prosthesis Trials.Yu Xia & Qiushi Ren - 2013 - Science and Engineering Ethics 19 (3):1099-1106.
Evaluating the Risks and Benefits of Phase II and III Cancer Clinical Trials: A Look at Institutional Review Board Members in the Netherlands.A. W. Musschenga, H. E. M. Van Luijn, N. K. Aaronson & R. B. Keus - unknown
A Study in Contrasts: Eligibility Criteria in a Twenty-Year Sample of NSABP and POG Clinical Trials.Abraham Fuks, Charles Weijer, Benjamin Freedman, Stanley Shapiro, Myriam Skrutkowska & Amina Riaz - unknown
Phase I oncology trials: why the therapeutic misconception will not go away.W. Glannon - 2006 - Journal of Medical Ethics 32 (5):252-255.
Uncertainty and the ethics of clinical trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
Are explanatory trials ethical? Shifting the burden of justification in clinical trial design.Kirstin Borgerson - 2013 - Theoretical Medicine and Bioethics 34 (4):293-308.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Involvement and (Potential) Influence of Care Providers in the Enlistment Phase of the Informed Consent Process: the case of aids clinical trials.Mary-Rose Mueller - 2004 - Nursing Ethics 11 (1):42-52.
Psychotropic drugs and paediatrics: a critical need for more clinical trials.Carl L. Tishler & Natalie S. Reiss - 2012 - Journal of Medical Ethics 38 (4):250-252.

Analytics

Added to PP
2014-02-02

Downloads
28 (#560,541)

6 months
4 (#790,778)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Amit Sharma
Delhi College of Engineering

Citations of this work

Ethical Perceptions of Genetically Modified Crops in Malaysia.Latifah Amin, N. A. Ahmad Azlan & J. Ahmad - 2014 - Eubios Journal of Asian and International Bioethics 24 (2):50-60.

Add more citations

References found in this work

Ethics at Phase 0: Clarifying the Issues.Jonathan Kimmelman - 2007 - Journal of Law, Medicine and Ethics 35 (4):727-733.

Add more references